TECH has compiled in this complete university program the most current scientific developments and postulates, elaborated by a teaching team of the highest academic level. Enroll now” 

This evolution in surgical and anesthetic techniques has been possible thanks to technological and pharmacological developments, but basically to the deepening of knowledge of the pathophysiological changes that occur in the different contexts of surgery, mainly during extracorporeal circulation. 

This Professional master’s degree in Cardiovascular Surgery focuses on providing the most advanced knowledge to be implemented both in the field of clinical practice management, as well as in the framework of daily activity, giving the possibility to streamline and maximize the ability to make decisions among the different possible alternatives and choose those that best meet the requirements of the cases presented. Therefore, the establishment of priorities and allocation of available resources must be carried out taking into account the most advanced scientific basis. 

The specialist will study an up-to-date and detailed review of the main areas of action in cardiac surgery taking into consideration the importance of joint decisions and the heart team to address the different strategies of medical, percutaneous and surgical treatment in valvular pathologies, ischemic and congenital heart disease; aortic pathologies.

This, among other aspects developed in depth in the syllabus of this up-to-date program, which is taught in a 100% online format, for the flexibility and freedom of organization of the student, setting their own time and mode of study. Undoubtedly, an advantage for the most demanding schedules of the specialist at the present time, which allows an advance in their preparation and to obtain a new qualification in 12 months. In addition, the university degree includes 10 comprehensive Masterclasses taught by a leading international expert in this medical-surgical field.

This program will provide you with 10 exclusive Masterclasses, developed by a renowned international expert in Cardiovascular Surgery”

This Professional master’s degree in Cardiovascular Surgery contains the most complete and up-to-date scientific program on the market.The most important features include:

• Practical cases presented by experts in Cardiovascular Surgery 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice 
• Practical exercises where the process of self-assessment can be used to improve learning 
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions for experts and individual reflection work 
• Content that is accessible from any fixed or portable device with an Internet connection

A high-level teaching team has designed this program, which brings a unique background to your professional profile" 

The program’s teaching staff includes professionals from the industry who contribute their work experience to this program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts. 

Add new procedures, techniques and proven scientific methods to your skills"

Access the most up-to-date content on the different heart diseases and their comprehensive approach"

This Professional master’s degree in Cardiovascular Surgery is framed in an effective teaching methodology based onRelearnig, of which TECH is a leader and has been revolutionizing the foundations of the current university environment, as it allows the rapid learning of concepts and their easy understanding. Together with the variety of multimedia resources and audiovisual content, they make the program dynamic and easy to follow, through any device with an Internet connection. There will be 10 study modules, based on a specific syllabus for the professional who wishes to deepen or recycle in the most advanced techniques of Cardiovascular Surgery.

A program that shows you the most cutting-edge techniques and the most up-to-date procedures in the medical environment in Cardiovascular Surgery"

Module 1. Anatomy and Pathophysiology of the Cardiovascular System

1.1. Embryology
1.2. Anatomy

1.2.1. Cardiac Cavities
1.2.2. Atrial Septum and Interventricular Septum
1.2.3. Heart Valves

1.3. Biochemistry of the Heart

1.3.1. Metabolic Regulation
1.3.2. Regulation of Oxygen Consumption
1.3.3. Plasma Lipoproteins

1.4. Conduction System
1.5. Coronary Anatomy and Coronary Pathophysiology
1.6. Large Vessels and Peripheral Vascular System
1.7. Physiology of the Cardiovascular Apparatus
1.8. Anatomophysiology of Pulmonary Circulation
1.9. Hemostasis and Blood Coagulation
1.10. Update on Cardiovascular Pharmacology

Module 2. Extracorporeal Circulation ECC

2.1. The History of ECC
2.2. General Principles of ECC
2.3. ECC Components

2.3.1. Mechanical Pumps
2.3.2. Oxygenators
2.3.3. Heat Exchanger
2.3.4. Circuits and Filters

2.4. Hypothermia

2.4.1. Physiology of Hypothermia
2.4.2. pH Control
2.4.3. Hypothermia Techniques

2.5. Ischemia-Reperfusion

2.5.1. Free radicals
2.5.2. High-Energy Phosphates
2.5.3. Calcium
2.5.4. Vascular Endothelium

2.6. Myocardial Protection Methods

2.6.1. Basic Principles of Cardioplegia
2.6.2. Types of Cardioplegia

2.7. Secondary Effects of ECC

2.7.1. Coagulation Alterations
2.7.2. Pulmonary Alterations
2.7.3. Neurological Alterations
2.7.4. Renal Disorders
2.7.5. Inflammatory Response

2.8. Monitoring During ECC

2.8.1. Cardiovascular Monitoring
2.8.2. Safety Devices
2.8.3. Pump Flows
2.8.4. Blood Gases
2.8.5. Heparinization

2.9. Cannulation Techniques

2.9.1. Types of Cannulas
2.9.2. Access for Cannulation
2.9.3. Special Situations
2.10. Incidents in ECC

Module 3. Perioperative Care

3.1. Preoperative Optimization

3.1.1. Risk Assessment
3.1.2. Nutritional Status
3.1.3. Anemia
3.1.4. Diabetes Mellitus
3.1.5. ATB Prophylaxis

3.2. Intraoperative

3.2.1. Monitoring
3.2.2. Anesthetic Induction and Maintenance
3.2.3. Fluid Use
3.3.4. Pulmonary Hypertension

3.3. Cardiovascular System

3.3.1. Volemia and Contractility
3.3.2. Postoperative AMI
3.3.3. Arrhythmias
3.3.4. Cardiopulmonary Arrest and Cardiopulmonary Resuscitation

3.4. Low-Energy Expenditure Syndrome

3.4.1. Monitoring and Diagnosis
3.4.2. Treatment

3.5. Respiratory System

3.5.1. Postoperative Changes in Pulmonary Function
3.5.2. Ventilator Management
3.5.3. Pulmonary Complications

3.6. Kidney Function

3.6.1. Kidney Pathophysiology
3.6.2. Predisposing Factors for Kidney Failure
3.6.3. Prevention of Kidney Failure
3.6.4. Treatment of Kidney Failure

3.7. Nervous System. Neurological Damage

3.7.1. Types of Neurological Damage
3.7.2. Risk Factors
3.7.3. Etiology and Prevention
3.7.4. Neuropathy in Critically Ill Patients

3.8. Hematological Complications

3.8.1. Postoperative Bleeding
3.8.2. Diagnosis of Coagulopathies
3.8.3. Prevention of Bleeding
3.8.4. Treatment

3.9. Infections

3.9.1. Pneumonia Associated with Mechanical Ventilation
3.9.2. Infection of Surgical Wounds
3.9.3. Infections Associated with Catheter Devices
3.9.4. Antibiotic Prophylaxis

3.10. Optimization of Blood Derivative Transfusion

Module 4. Ischemic Heart Disease

4.1. Clinical Manifestations of Myocardial Ischemia and Myocardial Infarction

4.1.1. Coronary Circulation: Pathophysiology of Cardiac Ischemia
4.1.2. Stable Angina
4.1.3. Non-ST-Elevation Acute Coronary Syndrome (NSTEACS)
4.1.4. ST-Elevation Acute Coronary Syndrome (STEACS)

4.2. Diagnosis

4.2.1. Electrocardiographic Criteria
4.2.2. Enzymatic Modifications
4.2.3. Non-Invasive Imaging Techniques
4.2.4. Stress Test. Myocardial Feasibility Studies
4.2.5. Non-Invasive Imaging Techniques

4.3. Clinical Decisions

4.3.1. Heart Team
4.3.2. Complexity Assessment of Coronary Artery Disease and Surgical Risk
4.3.3. Analysis of Clinical Practice Guidelines
4.3.4. Decision on the Priority of Intervention
4.3.5. Medical Treatment of Ischemic Heart Disease

4.4. Management and Treatment of NSTE-ACS

4.4.1. The Heart Attack Code
4.4.2. Thrombolytic Treatment
4.4.3. Percutaneous Treatment

4.5. Technical Considerations in the Surgical Treatment of Ischemic Heart Disease I

4.5.1. Cannulation: Exposure of the Coronary Arteries
4.5.2. Types of Grafts. Graft Extraction
4.5.3. Graft Configuration. Types of Anastomoses
4.5.4. Compound Grafts

4.6. Technical Considerations in the Surgical Treatment of Ischemic Heart Disease II

4.6.1. Non-ECC Surgery
4.6.2. Flow Measurement of Coronary Grafts
4.6.3. MIDCAB: TECAB. Robotics
4.6.4. Results

4.7. Technical Considerations in the Surgical Treatment of Ischemic Heart Disease III 

4.7.1. Acute Ischemic Mitral Insufficiency
4.7.2. Post-Infarction VSD
4.7.3. Free Wall Breakage
4.7.4. Ventricular Aneurysm

4.8. Technical Considerations in the Surgical Treatment of Ischemic Heart Disease IV

4.8.1. Surgery for Chronic Ischemic Mitral Insufficiency
4.8.2. Coronary Artery Surgery Combined with Peripheral Vascular Disease
4.8.3. Coronary Surgery and Pre-Operative Antiplatelet Therapy

4.9. Cardiogenic Shock Management

4.9.1. Medical Treatment
4.9.2. IABP
4.9.3. ECMO
4.9.4. Ventricular Assistance Devices

4.10. Relevant Studies in Ischemic Heart Disease

4.10.1. SYNTAX
4.10.2. EXCEL and NOBLE. Left Main Coronary Artery Pathology
4.10.3. ARTS Arterial Grafts
4.10.4. FAME. Multivessels

Module 5. Valvular Heart Disease

5.1. Etiopathogenesis
5.2. Valvular Heart Team. Specific Units
5.3. Types of Valve Prostheses

5.3.1. Historical Evolution of Valve Prostheses
5.3.2. Mechanical Prostheses
5.3.3. Biological Prostheses
5.3.4. Homograft
5.3.5. Xenografts
5.3.6. Autografts

5.4. Mitral Valve

5.4.1. Anatomy and Function
5.4.2. Pathophysiology
5.4.3. Replacement and Repair Techniques

5.5. Tricuspid Valve

5.5.1. Anatomy and Function
5.5.2. Pathophysiology
5.5.3. Replacement and Repair Techniques

5.6. Aortic Valve

5.6.1. Anatomy and Function
5.6.2. Pathophysiology
5.6.3. Replacement and Repair Techniques

5.7. Pulmonary Valve

5.7.1. Anatomy and Function
5.7.2. Pathophysiology
5.7.3. Replacement and Repair Techniques

5.8. Minimally Invasive Surgery
5.9. Results of Valvular Surgery. Studies
5.10. Endocarditis

5.10.1. Etiology
5.10.2. Indications
5.10.3. Risk Scores
5.10.4. Treatment

Module 6. Aortic Pathology

6.1. Anatomy and Function of the Aortic Root
6.2. Pathology and Treatment of the Aortic Root
6.3. Thoracic Aortic Aneurysm

6.3.1. Etiopathogenesis
6.3.2. Natural History
6.3.3. Treatment

6.4.  Thoracoabdominal Aneurysm 
6.5. Acute Aortic Syndrome

6.5.1. Classification
6.5.2. Diagnosis

6.6. Surgical Treatment of Acute Aortic Syndrome
6.7. Adjuvant Techniques in the Surgical Treatment of Acute Aortic Syndrome
6.8. Aortic Arch Surgery
6.9. Percutaneous Treatment
6.10. Aortitis

Module 7. Congenital Heart Disease

7.1. General Physiology of Congenital Heart Disease

7.1.1. Major Syndromes
7.1.2. Palliative Techniques

7.2. Patent Ductus Arteriosus

7.2.1. Aortopulmonary Window
7.2.2. Fistula of the Sinus of Valsalva
7.2.3. Aorto-Ventricular Tunnel

7.3. Obstructions to Systemic Flow

7.3.1. Aortic Subvalvular Stenosis
7.3.2. Valvular Aortic Stenosis
7.3.3. Supravalvular Aortic Stenosis and Aortic Coarctation
7.3.4. Interrupted Aortic Arch

7.4. Atrial Septal Defect and Ventricular Septal Defect

7.4.1. Atrioventricular Canal
7.4.2. Truncus Arteriosus

7.5. Tetralogy of Fallot

7.5.1. Pulmonary Atresia with VSD and MAPCAS

7.6. Transposition of the Main Arteries. Double Outlet Right Ventricle
7.7. Hypoplastic Left Heart Syndrome

7.7.1. Three-Stage Management of Univentricular Physiology

7.8. Pulmonary Venous Return Anomalies

7.8.1. Total and Partial Anomalous Pulmonary Venous Return
7.8.2. Heterotaxia

7.9. Congenitally Corrected Transposition of the Great Arteries
7.10. Vascular Rings. Coronary Abnormalities

Module 8. Arrhythmias

8.1. Cardiac Electrophysiology

8.1.1. Cellular Electrophysiology

8.1.1.1. Membrane Potential
8.1.1.2. Ion Channels
8.1.1.3. Action Potential
8.1.1.4. GAP Junctions
8.1.1.5. Cardiac Muscle Properties

8.1.2. Classification and Mechanisms of Arrhythmias

8.2. 12-Lead Electrocardiogram: General Information for Its Correct Interpretation
8.3. Sudden Death of Cardiac Origin and Ventricular Tachycardia

8.3.1. Associated Diseases
8.3.2. Triggering Mechanisms. Patients at Risk
8.3.3. Prevention

8.4. Tachyarrhythmias

8.4.1. Atrial Fibrillation
8.4.2. Flutter
8.4.3. Supraventricular Tachycardias

8.5. Bradyarrhythmias

8.5.1. Sinus Dysfunction
8.5.2. Sinoatrial Block
8.5.3. Atrioventricular Block
8.5.4. Intraventricular Conduction Abnormalities

8.6. Electrostimulation Devices I

8.6.1. Pacemaker
8.6.2. Defibrillators
8.6.3. Cardiac Resynchronization Therapy (CRT)
8.6.4. Indications

8.7. Electrostimulation Devices II

8.7.1. Implantation Techniques
8.7.2. Complications

8.8. Removal of Electrostimulation Electrodes
8.9. Atrial Fibrillation Surgery

8.9.1. Theoretical Principles and History
8.9.2. Available Tools
8.9.3. Surgical Technique

8.10. Left Atrial Appendage Closure

8.10.1. Research. Prevail. Protect. Laaos
8.10.2. Percutaneous Closure
8.10.3. Surgical Closure

Module 9. Treatment of Other Cardiovascular Diseases, Transcatheter Valve Implantation and Concomitant Conditions

9.1. Surgical Management of Cardiac and Great Vessel Trauma

9.1.1. Blunt
9.1.2. Open

9.2. Cardiomyopathies

9.2.1. Dilated Cardiomyopathy
9.2.2. Hypertrophic Cardiomyopathy
9.2.3. Restrictive Cardiomyopathy

9.3. Pericardial Diseases

9.3.1. Pericardial Effusion and Tamponade
9.3.2. Constrictive Pricarditis
9.3.3. Cysts and Tumors

9.4. Cardiac Tumors
9.5. Pulmonary Embolism

9.5.1. Pathophysiology, Prevention and Treatment
9.5.2. Pulmonary Thromboendarterectomy

9.6. Ventricular Assists and ECMO
9.7. Cardiac Transplantation

9.7.1. History of Heart Transplant
9.7.2. Surgical Techniques
9.7.3. Donor and Recipient Selection
9.7.4. Immunosuppression

9.8. Transcatheter Valvular Treatment of the Aortic Valve
9.9. Transcatheter Valvular Treatment of the Mitral Valve

9.9.1. Transcatheter Mitral Valve Implantation
9.9.2. Transapical Neo-String Implantation

9.10. Cardiovascular Surgery and Concomitant Diseases

9.10.1. Preoperative Assessment
9.10.2. Fragility
9.10.3. Renal Insufficiency
9.10.4. Respiratory Failure
9.10.5. Digestive Pathology
9.10.6. Coagulation Disorders
9.10.7. Pregnancy

Module 10. New Technologies and Imaging Techniques. Statistics

10.1. New Technologies in Cardiovascular Surgery

10.1.1. New Polymer Prostheses
10.1.2. Vest/Duragraft
10.1.3. 3D Printing
10.1.4. Augmented Reality
10.1.5. Robotics

10.2. Transthoracic Echocardiography
10.3. Transesophageal Echocardiogram
10.4. Imaging Techniques in Cardiac Pathology

10.4.1. Cardiac CT
10.4.2. Cardiac MRI
10.4.3. Perfusion Studies
10.4.4. PET/CT

10.5. Statistics I for Surgeons

10.5.1. Sample Collection
10.5.2. Graphic Representation

10.6. Statistics II for Surgeons

10.6.1. Statistical Inference
10.6.2. Proportion Comparison
10.6.3. Comparison of Averages

10.7. Statistics III for Surgeons

10.7.1. Regression Analysis
10.7.2. Linear Regression
10.7.3. Logistic Regression
10.7.4. Survival Studies

10.8. Care Management

10.8.1. Quality Criteria
10.8.2. Records and Databases
10.8.3. Criteria for the Timing of Cardiovascular Interventions

10.9. Research Methodology

10.9.1. Design
10.9.2. Ethics
10.9.3. Critical Reading of Articles
10.9.4. Evidence-Based Medicine

10.10. Past, Present and Future of Cardiovascular Surgery

You will be able to ask the teachers any questions you may have about the syllabus, with full and personalized assistance”